Moors & Cabot, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Moors & Cabot, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,983,731
+1.8%
29,292
+0.9%
0.20%
+3.6%
Q2 2023$2,930,675
+6.0%
29,042
-3.3%
0.20%
+2.6%
Q1 2023$2,764,331
+2.3%
30,047
+0.9%
0.19%
+1.1%
Q4 2022$2,701,778
+15.0%
29,782
-3.7%
0.19%
+5.0%
Q3 2022$2,350,000
-11.0%
30,920
-1.0%
0.18%
-5.8%
Q2 2022$2,639,000
-2.9%
31,217
+0.8%
0.19%
+13.8%
Q1 2022$2,717,000
+2.2%
30,965
+1.9%
0.17%
+1.8%
Q4 2021$2,659,000
-47.3%
30,402
-51.0%
0.16%
-48.3%
Q3 2021$5,050,000
+82.6%
62,000
+104.5%
0.32%
+63.4%
Q2 2021$2,766,000
+8.5%
30,317
+1.5%
0.19%
-0.5%
Q1 2021$2,549,000
-20.0%
29,855
-11.5%
0.20%
-27.2%
Q4 2020$3,185,000
+7.6%
33,749
-0.8%
0.27%
-3.6%
Q3 2020$2,959,000
-2.8%
34,020
-2.4%
0.28%
-14.2%
Q2 2020$3,043,000
+28.4%
34,839
+20.6%
0.32%
-5.8%
Q1 2020$2,370,000
-33.1%
28,879
-22.9%
0.34%
-3.1%
Q4 2019$3,541,000
+8.7%
37,433
-0.1%
0.36%
-1.1%
Q3 2019$3,259,000
-1.1%
37,482
+3.8%
0.36%
-14.1%
Q2 2019$3,296,000
-1.4%
36,107
+3.8%
0.42%
-8.1%
Q1 2019$3,342,000
+15.2%
34,794
+3.0%
0.46%0.0%
Q4 2018$2,900,000
-4.2%
33,776
-3.9%
0.46%
+23.0%
Q3 2018$3,027,000
+16.5%
35,132
+2.2%
0.37%
+5.7%
Q2 2018$2,599,000
-19.0%
34,381
-13.3%
0.35%
-17.5%
Q1 2018$3,207,000
-4.4%
39,665
-0.8%
0.42%
-4.5%
Q4 2017$3,353,000
-5.5%
39,977
-3.0%
0.44%
-13.5%
Q3 2017$3,547,000
+11.2%
41,223
+7.9%
0.51%
-3.2%
Q2 2017$3,190,000
+25.4%
38,195
+11.4%
0.53%
+23.5%
Q1 2017$2,543,000
-6.2%
34,301
-7.8%
0.43%
-3.8%
Q4 2016$2,712,000
-7.7%
37,196
+0.1%
0.45%
-9.2%
Q3 2016$2,937,000
+7.5%
37,170
+12.3%
0.49%
+2.3%
Q2 2016$2,733,000
+14.6%
33,094
+0.2%
0.48%
+11.6%
Q1 2016$2,385,000
-15.9%
33,017
+0.3%
0.43%
-17.1%
Q4 2015$2,836,000
-10.8%
32,917
-4.8%
0.52%
-11.6%
Q3 2015$3,180,000
-4.0%
34,590
+2.9%
0.59%
+8.9%
Q2 2015$3,314,000
+3.7%
33,618
+3.8%
0.54%
+1.1%
Q1 2015$3,197,000
+8.6%
32,376
+2.1%
0.53%
+6.8%
Q4 2014$2,943,000
-2.3%
31,711
-1.1%
0.50%
-2.5%
Q3 2014$3,012,000
+5.6%
32,076
+1.9%
0.51%
+6.4%
Q2 2014$2,852,000
+12.0%
31,485
+5.1%
0.48%
-25.3%
Q1 2014$2,547,00029,9570.64%
Other shareholders
NOVARTIS A G shareholders Q4 2023
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders